BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Review Article
Year : 2026  |  Volume : 17  |  Issue : 1  |  Page : 8383-8387 Full Version
Review: microspheres its method of preparation and industrial applications.
Int J Biol Med Res. 2026; 17(1): 8383-8387  |  DOI: 10.65048/ijbmr/2026.17.1.8383.1011
Vijay S Sonavane¹, Rohan J Jadhav², Amit V Pondkule³, Dr. Sudarshan N Nagrale 4
¹Dattakala Institute of Pharmaceutical Science &Research, Swami Chincholi, Maharashtra, India
²,4,DKSS Dattakala College of pharmacy,Swami Chincholi ,Maharashtra, India
³Anusaya Institute of Pharmacy, Swami Chincholi , Maharashtra, India
Correspondence Address :
Amit Vilasrao Pondkule,
Institute of Pharmaceutical Science and Research (for girls),
Swami Chincholi. Maharashtra, India E-mail: pondkulemit@gmail.com
Received: September 26, 2025 Accepted: November 2, 2025 Published: January 3, 2026

Abstract
Controlled release drug delivery employs drug-encapsulating devices from which therapeutic agents may be released at controlled rates for long periods of time, ranging from days to months. Polymeric microspheres are ideal vehicles for many controlled delivery applications due to their ability to encapsulate a variety of drugs, biocompatibility, high bioavailability and sustained drug release characteristics. Research discussed in this review is focused on improving large-scale manufacturing, maintaining drug stability and enhancing control of drug release rates. Drug delivery systems (DDS) that can precisely control the release rates or target the introduction of a medication to a specific bodily location has a huge influence on the health- care system. Throughout the course of therapy, the ideal drug delivery system distributes the medication at a pace determined by the body's needs, and it delivers the active component solely to the site of action. As a result, carrier innovation provides an intelligent method to drug delivery by attaching the drug to a carrier particle, such as microspheres, nanoparticles, or liposomes, which modifies the drug's release and absorption properties.
Keywords
Key words: Microsphere, Magnetic Microsphere, Freeze Drying, Gene Delivery

Introduction

Microspheres are tiny spherical particles with sizes ranging from one millimeter to one thousand millimeters. They are spherical, free-flowing particles made up of biodegradable proteins or synthetic polymers. Microcapsules and micrometrics are two different kinds of microspheres that are referred as Microcapsules are encapsulated substances that are enclosed by a unique capsule wall. Micrometrics, in which the imprisoned material is distributed throughout the framework. Microspheres and micro-particles are two terms used interchangeably to describe microspheres. [1]

Advantages

  1. Theygivesteady andextendedeffect.
  2. Reducesthemultipledosagesperday
  3. Microspheres aretinyandeasytotake

Limitation

  1. Variable releasefromtheformulations.
  2. Effectoffoodmaygreatinthiskindofformulationandleadcontrolledreleasewillvary.
  3. Contrastsinthereleaserate startingwith onedosethenonto thenext.
  4. Controlled release plans by and large contain a higher medication burden and thus anyloss of integrity of the release characteristics of the dosage form may lead to potentialtoxicity.[2]

TYPES OF MICROSPHERES

  1. Microspheres of Mucoadhesive compound
  2. Microspheres of Magnetic compound]
  3. Microspheresof Floatingcompound
  4. Microspheres of   Radioactive compound
  5. Microspheres of Bio adhesive compound [3]

Microspheres ofMucoadhesive Compound

Among all drug delivery methods, oral controlled release systems remain the most well-known. It has a few advantages over traditional methods, such as a better plasma level profile, reduced dosage, and toxic city, among others. The incapacity of controlled release dosage forms to build the living arrangement time of the dosage form in the stomach and proximal section of the small digestive system is a common concern. This might be related to the stomach's fast gastrointestinal transit phenomena, Because the majority of drug compounds are absorbed from the upper portion of the digestive system, this may subsequently release the degree of absorption of a variety of drugs. As a result, maintaining release characteristics that persist at the absorption site for a longer length of time is beneficial. The creation of an oral drug delivery mucoadhesive modified release system is one of the techniques that have been explored to extend the stomach residence duration of the dose form at the site of absorption. For some years, microsphere carrier systems built from found naturally biodegradable polymers have piqued interest in the field of prolonged drug administration. Lately, dosage formulations that can accurately regulate release rates have been available.

The ability to target medicines to a specific bodily location has had a huge effect on the design of new therapeutic methods. Microspheres are a key component of these new medication delivery systems. They come in a variety of shapes and sizes and are made from a variety of polymers. However, because to their brief residence duration at the appropriate concentration, the success of these microspheres is restricted As a result, it would be beneficial to have ways of ensuring that the drug delivery system is in close proximity to the absorbent barriers. It can be accomplished by combining cohesion properties with microspheres to create mucoadhesive microspheres. Due to a high surface-to-volume ratio and a considerably closer interaction with the mucus layer, mucoadhesive microspheres provide features such as efficient absorption and increased medication bioavailability, and specific targeting of drugs to the absorption site mucoadhesive and biodegradable polymers undergo selective uptake by the M cells of payer patches in GI.

Microspheres as a carrier polymer for microspheres and polyethylene glycol as a microparticles carrier polymeric, sodium chitosan as a polymeric matrix for sustained release medication delivery owing to its hydrogel forming capabilities.[4]

Microspheres of Magnetic Compound

This type of delivery method is extremely important since it confines the medication to the illness location. A higher amount of freely circulating medication can be substituted with a smaller amount of magnetically focused drug in this situation. Magnetic transporters obtain magnetic responses to a magnetic field from fused materials like as chitosan and dextran, which are employed in magnetic microspheres. Medicinal magnetic microspheres, on the other hand, are used to deliver chemotherapy agents to liver tumors. This method can also be utilized to concentrate medications such as proteins and peptides.

Magnetic microspheres are macromolecular particles that are tiny enough to pass via vasculature without causing embolic blockage (4m) yet electromagnetic enough to be caught in micro-vessels and pulled into neighboring tissues by a magnetosphere of 0.5-0.8 tau. Magnetic microspheres are critical in directing the medication to the illness location. A higher amount of generally circulated medication can be substituted by a lesser proportion of magnetically focused drug in this case. [5]

Microspheres of Floating Compound

Floating microspheres are bubbly medication delivery methods that are enteritis. Floating microspheres are sometimes referred to as hollow microspheres, micro-balloons, or floating micro-particles. From a technical standpoint, floating microspheres are circular empty particles without even a center. The pharmaceuticals are progressively released at the desired pace, resulting in increased stomach retention and less fluctuations in drug levels. The goal of this study is to concentrate on the preparation technique as well as the many aspects that influence the performance and evaluation of floating microspheres. The literature investigation is an excellent source of thorough information. [6]

Microspheres of Radioactive Compound

Radio embolization is a therapy that is used to prevent blood clots When microspheres 10- 30 nanometer bigger than vasculature come through, they are tapped in the first capillary bed. They're injected into the supply lines leading to the tumor of interest. As a result, radioactive microspheres in each of these situations provide a significant radiation exposure to the impact zone while causing no damage to the surrounding organs. It varies from a medication delivery system in that radiation is not emitted from microspheres but rather acts from a radioisotope within a certain distance, and the distinct types of radioactive microspheres are transmitters and emissions. It provides new options for patients who require medicines to be administered to tumors and other disease sites.

Diagnostic uses of radioactive microspheres

Example

    1. Gated blood pool study
    2. Diagnostic radio embolization
    3. Liver and spleen imaging
    4. Bone marrow imaging
    5. Tumor imaging
    6. Gastrointestinal travel examines. [7]

Microspheres of Bio Adhesive Compound

Adhesion is defined as the ability of a medication to adhere to a membrane using the adhesive properties of a water-soluble polymer. Bio adhesion is the adherence of a drug delivery device to a mucous membrane such as the buccal, ocular, rectal, or nasal mucosa.[8][9]

METHODS OF PREPARATION

Preparation of microspheres ideal properties:

  • The high concentrations of the drug.
  • With pharmacologically acceptable shelf life.
  • Regulated unit size for injection.
  • Prolonged release of active reagent with respect to time. [10]

Different types of techniques are employed in preparation of microspheres

Single Emulsion Technique

                     The micro particulate carriers of characteristic polymers of regular polymers for example those of proteins and carbohydrate are prepared by single emulsion procedure. The natural polymers are broken up or dispersed in fluid medium followed by disperse in non-watery medium like oil Next cross connecting of the dispersed globule is done. The cross connecting can be accomplished either by methods for heat or by chemical cross linkers. The synthetic cross-linking agent is glutaraldehyde, formaldehyde, di corrosive chloride etc. heat denaturation isn't reasonable for thermolabile substances. Compound cross linking suffers the disadvantage of excessive exposure of active ingredient to chemicals if added at the time of preparation and then subjected to centrifugation, washing, and separation. [11]

Double Emulsion Technique

                     Includes the development of the numerous emulsions or the double emulsion of type w/o/w and is most appropriate to the water dissolvable drugs, peptides, proteins and the antibodies. The aqueous protein solution is dispersed in a lipophilic organic continues phase which is for the most part comprised of polymer solution that in eventually encapsulates protein contained in dispersed aqueous phase. The essential emulsion is then exposed to the homogenization before expansion to aqueous solution of PVA this outcome in development of double emulsion which is then subjected to solvent removal by solvent evaporation maintaining the emulsion at reduced pressure or by stirring so that organic phase evaporates out.

Sonication Technique

                     The technique name itself is self-explanatory, it just includes a straightforward sonication for certain timeframe till an ideal size of albumin microspheres are gotten.   The albumin so a s lotion of wanted focus is taken which is sonicated to this include the drug which will at that point structure intra-chain cross-interface with cysteine deposits of albumin chains. A stable preparation of air-filled human albumin microspheres (Albumen) can be prepared by sonication technique. The microspheres ranged in size from 1to10 am with 99% of particles smaller than 10 am. The mean size was 5 am, which is small enough to pass freely through the pulmonary capillary circulation. [12]

Spray Drying

Spray drying is widely used in the industry for microencapsulation of volatiles, probiotics, and viable cells and reasonable cells. Other than the conspicuous disadvantage (high misfortune, low yield), the various focal points make this innovation exceptionally well known (uniform molecule size, all means did in one device, utilization of natural solvents, the ability of exemplifying warmth labile materials). The emulsion is sprayed into a chamber, where hot air dries the particles, and subsequently, standard molded, micron- sized, uniform particles are made. The expelled wax particles can be set utilizing hardening, which offers an answer for implanting hydrophilic segment to perform sustained release by via the slow erosion of the wall in the biological medium. [13]

Solvent Evaporation Technique

                     Way back in 1933 Hickey et al prepared microcapsules using this technique   but the solvent evaporation technique was fully developed in 1979. This technique is based on the evaporating of the internal phase of an emulsion by agitation. Generally, the polymeric coat material is dissolved in a volatile organic solvent. The drug core is then dissolved or dispersed in the above polymer solution to form a suspension, an emulsion or a solution Then the organic phase is emulsified under agitation in a dispersing phase consisting of a nonsolvent of the polymer, which is immiscible with the organic solvent, which contains an appropriate emulsifying agent. Once the emulsion is stabilized, agitation is maintained and the solvent evaporates after diffusing through the continuous phase resulting in solid microspheres The microspheres are recovered by filtration or centrifugation and are washed and dried Several researchers have prepared microspheres of various bioactive materials using this technique and its variants. Although the concept of the solvent evaporation technique is relatively simple, the physicochemical parameters governing this process are very complex This system is characterized by the existence of several interfaces through which mass transfer occurs during particle formation. Mathematical models based on mass transfer were derived and used to predict microsphere properties prepared using solvent evaporation/ extraction methods. The formation of solid microspheres is brought about by the evaporation of the volume of solvent L1 at interface L2/G. During the course of solvent evaporation, a partitioning is produced across the interface L1/ L2 from the dispersed phase to the continuous phase leading to the formation of solid microspheres. The partitioning across the interface L1/L2 is, however, not limited to organic solvent; the active principle may also partition to some extent at this interface. The rapidity and importance of these different transfer processes have a direct effect on micro particle formation. The rate of evaporation can be modified by rapid dilution of external phase, raising the temperature of external phase. Another way is by extracting the solvent using a common solvent for both internal and external phases Thus, by studying the various governing parameters, the establishment of optimal conditions for the formulation of individual polymer/drug can be achieved. The solvent evaporation method has attracted the most attention because of its ease of use and scaleup and lower residual solvent potential compared to other processes. [14]

Freeze Drying

Freeze drying also known as lyophilization, is widely used for pharmaceuticals to improve the stability and long-term storage of labile drugs. Lyophilization or Freeze-drying fills an important need in pharmaceutical manufacturing technology by allowing drying of heat sensitive drugs and biologicals at low temperature under conditions that allow removal of water by sublimation, or a change of phase from solid to vapor without passing through the liquid phase. The most common application of pharmaceutical freeze drying is in the production of injectable dosage forms, the process is also used in the production of diagnostics and, occasionally, for oral solid dosage forms where a very fast dissolution rate is desired Lyophilization or freeze drying is a process in which water is removed from a product after it is frozen and placed under a vacuum, allowing the ice to change directly from solid to vapor without passing through a liquid phase. Lyophilization is performed at temperature and pressure conditions below the triple point, to enable sublimation of ice The entire process is performed at low temperature and pressure, hence is suited for drying of thermolabile compounds. Steps involved in lyophilization start from sample preparation followed by freezing, primary drying and secondary drying, to obtain the final dried product with desired moisture content. The concentration gradient of water vapor between the drying front and condenser is the driving force for removal of water during lyophilization the vapor pressure of water increases with an increase in temperature during the primary drying.   Therefore, primary drying temperature should be kept as high as possible, but below the critical process temperature, to avoid a loss of cake structure.   This critical process temperature is the collapse temperature for amorphous substance, or eutectic melt for the crystalline substance. During freezing, ice crystals start separating out until the Solution becomes maximally concentrated   on further cooling, phase separation of the solute and ice takes place. [15]

APPLICATION OF MICROSPHERES IN PHARMACEUTICAL INDUSTRY

Microspheres developed using polymer exhibits favorable biological behavior such as bio adhesion, permeability enhancing properties, and interesting physicochemical characteristics, which make it a unique material for the design of ocular drug delivery vehicles Eg Chitosan, Alginate, Gelatin.

Oral Drug Delivery

The capacity of microspheres containing polymer to frame films grant its utilization in the plan of film dosage form, as an option in contrast to pharmaceutical tablets. The pH sensitivity, combined with the reactivity of the essential amine groups, make microspheres more suitable for oral drug delivery applications. For example, Chitosan, Gelatin

Gene Delivery

Microspheres could be a valuable oral quality bearer reason for its adhesive and transport properties in the GI tract. For example, Chitosan, Gelatin, viral vectors, cationic liposome, polycation edifices and Gene treatment with DNA plasmids and furthermore delivery of insulin   It is additionally valuable in vaccine delivery likewise as the essential of a vaccine is security against the microorganism or its harmful item. Biodegradable drug delivery for vaccine that are given by Parenteral course may defeat the shortcoming of conventional vaccines. A few parenteral vaccines have been epitomized in biodegradable polymeric microspheres, including the tetanus and diphtheria antibody.

Nasal Drug Delivery

Polymer based drug delivery systems, for example, microsphere, liposomes and gels have been shown to have great bio adhesive attributes and swell effectively when in contact with the nasal mucosa expanding the bioavailability and living arrangement time of the medications to the nasal course. For example Starch, Dextran, Albumin, Chitosan + Gelatin 40

Intratumorally and Local Drug Delivery

In order to deliver paclitaxel at the tumor site in therapeutically important focus, polymer films are manufactured. Blend of medication has promising potential for use in controlled delivery in the oral cavity for example Gelatin, PLGA, Chitosan

Buccal Drug Delivery

Polymer is an excellent polymer to be used for buccal delivery because it has much / bio adhesive properties and can act as an absorption enhancer. Chitosan, Sodium alginate

Gastrointestinal Drug Delivery

Polymer granules having internal cavities prepared by de acidification when added to acidic and neutral media are found buoyant and provided a controlled release of the drug. e g Eudragit, Ethyl cellulose + Carbopol BSA, Gelatin

Transdermal Drug Delivery

Polymer has good film forming properties the drug release from the devices is affected by the membrane thickness and cross-linking of the film. e g Chitosan, Alginate, PLGA

Monoclonal Antibodies

Monoclonal antibodies or targeting microspheres are biologically immune microspheres. This type of targeting is used to achieve selective targeting to specific sites of the body organ Monoclonal. Antibodies are extremely specific molecules which bind to the specific part of the body system through which absorption takes place via

  1. Nonspecific adsorption and specific adsorption
  2. Direct coupling
  3. Coupling via reagents

Imaging

Diameter of microspheres plays an important role in determining the imaging of targeted sites using already labelled microspheres having radio activity. The microspheres injected via IV route apart from the portal vein will usually become entrapped in the area of lungs This phenomenon is specifically used for scintigraphy imaging of tumor masses in lungs using human serum albumin microspheres.

Topical Porous Microspheres

Micro sponges are porous microspheres having myriad of interconnected voids of size range 5 to 300µm these sponges having capacity to engulf the various active ingredients such as emollients, fragrances, essential oils which is used for the topical application.

MedicalApplication

Releaseofproteins,peptidesand hormonesovertheextendedperiod oftime

Passivetargetingofleakytumorvessels,activetargetingoftumorcells,antigens,bypaenteral route

MagneticMicrospherescanbeusedforusedforstemcellextractionandbonemarrowpurging

UsedforVariousdiagnostictestforinfectiousdiseaselikebacterial,viralandfungal

Radioactive Application

It can be beneficial for the embolization of various liver and spleen tumors which is used for radio synovectomy of local radiotherapy, arthritis, imaging of liver, bone marrow, local radiotherapy and even imaging of thrombus in deep vein thrombosis can be done.

Other Applications

Fluorescent microspheres can be used for membrane-based technology flow cytometry, cell biology, fluorescent linked immunosorbent assay Yttrium 90 can be used for primary treatment of carcinoma and also used for pre transplant management of HCC with promising results.

Colonic Drug Delivery

Polymer has been used for the specific delivery of insulin to the colon. E.g., Chitosan

Vaginal Drug Delivery

Polymer, modified by the introduction of thioglycolic acid to the primary amino groups of the polymer is widely used for the treatment of mycotic infections of the genitourinary tract.

E. g. Chitosan, Gelatin, PLGA 2

 

Conclusions

Current review paper concluded that Polymeric microspheres are ideal vehicles for many controlled delivery applications due to their ability to encapsulate a variety of drugs, biocompatibility, high bioavailability and sustained drug release characteristics. Research discussed in this review is focused on improving large-scale manufacturing, maintaining drug stability and enhancing control of drug release rates. This paper describes methods of microsphere fabrication and the major factors controlling the release rates of encapsulated drugs. Furthermore, recent advances in the use of polymer microsphere-based systems for delivery of single-shot vaccines, plasmid DNA and therapeutic proteins are discussed, as well as some future directions of microsphere research.

References

[1].RAJU B, RAO VU, Sujatha H, SAIKRISHNA K, Venkateshwar CH, KEERTHI L. Formulation and in vitro evaluation of mucoadhesivebuccal tablets of fluvastatin. Int. J. Adv. Pharm. Sci. 2016;5(6):2499-510.
[2].Xu HR, Chen WL, Chu NN, Li XN, Zhu JR. The difference in pharmacokinetics and pharmacodynamics between extended-release fluvastatin and immediate-release fluvastatin in healthy Chinese subjects. Journal of Biomedicine and Biotechnology. 2012 ;2012.
[3].Xiang Q, Wu W, Zhao N, Li C, Xu J, Ma L, Zhang X, Xia Q, Zhang Z, Wang J, Xu W. The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations. Asian journal of pharmaceutical sciences. 2020 15(2):264-72.
[4].Elim am H, El-Say KM, Cybulski AV, Khalil H. Regulation of autophagy progress via lysosomal depletion by fluvastatin nanoparticle treatment in breast cancer cells. ACS omega. 2020 ;5(25):15476-86.
[5].Kumar PJ, Munib YI, Misran G. Formulation and evaluation of pulsatile drug delivery of fluvastatin sodium. Journal of Chemical and Pharmaceutical Research. 2016;8(2):757-64.
[6].Al-Wahabi LH, Al-Saleem MS, Ahmed OA, Fahmy UA, Ilhaam NA, Eid BG, Abdel-Nami AB, Abdel-Magee WM, AL Rasheed MM, Shaly GA. Optimized conjugation of fluvastatin to hiv-1 that displays enhanced pro-apoptotic activity in hepg2 cells. International Journal of Molecular Sciences. 2020 ;21(11):4138.
[7].Akbari AH, Shah UH, Solanki S, Patel M, Sharia BN. Development and Validation of sensitive HPTLC method for quantitative analysis of fluvastatin sodium in bulk and pharmaceutical dosage form. International Journal of Pharmaceutical Research. 2014 ;6(2):73-8.
[8].Ponor RS, Ahmed AR, Cheuk R, Julia P, Sriramulu S, Madhapur A, Nithi H. Formulation and in vivo evaluation of mucoadhesivebuccal tablet of fluvastatin sodium. UPI Journal of Pharmaceutical, Medical and Health Sciences. 2020:16-25.
[9].Ghosh P, Brogdon NK, Stinchcombe AL. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin. Journal of pharmaceutical sciences. 2014 ;103(2):652-60.
[10].Singh S, Sharma N, Kanoujia N, Kaur G, Arora S. Development and validation of UV-spectrophotometer method for analysis of Fluvastatin sodium in polyethylene glycol 6000 and polyvinyl pyrrolidone K30 solid dispersions. Plant Archives. 2020;20(1):3365-71.
[11].El-Held AR, Fahmy UA. Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers. International journal of nanomedicine. 2015; 10:5797.
[12].Brefeldin SM, Ilhaam NA, Fahmy UA, Ahmed OA, as four HZ, Althaea AA, Aldawsari HM, Rig WY, Mahdi WA, Aghast AF, Altieri S. Cytotoxic and pro-apoptotic effects of a sub-toxic concentration of fluvastatin on OVCAR3 ovarian cancer cells after its optimized formulation to melittinnano-conjugates. Frontiers in Pharmacology. 2021:2500.
[13].Assaedi N. BIOADHESIVE BUCCAL DISCS OF FLUVASTATIN SODIUM. Al-Azhar Journal of Pharmaceutical Sciences. 2015 ;51(1):134-51.
[14].Sandhala D, Langalibalele S. New Method for the in vivo Estimation of Fluvastatin and its Application for Pharmacokinetic Studies in Rabbit. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH. 2020 1;54(4):1153-8.
[15].Rossi SF. Determination of Fluvastatin Sodium in Pharmaceutical Preparations Utilizing a Modified Carbon Paste Electrode. Chem. Mat. Res. 2015; 7:92-104.
 


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications